Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Pharmacia & Upjohn and Chiron establish HCV collaboration

Feb. 4, 1998

Prokinetic motilin agonists in development at Ohmeda

Jan. 30, 1998

Meiji Seika describes 5-HT3 partial agonists for GI disorders

Jan. 29, 1998

Vion prepares more active prodrug of beta-L-FD4C

Jan. 27, 1998

Randomized trial compares interferon alfa-2b + ribavirin to interferon alone for HCV

Jan. 26, 1998

Anti-H. pylori agents from Pfizer

Jan. 23, 1998

Pivotal Zadaxin trial to begin in Japan

Jan. 22, 1998

Combination HCV therapy receives priority classification from FDA

Jan. 21, 1998

Interim Maxamine phase I data reported

Jan. 19, 1998

Vertex researchers report 3-D structure of hepatitis C enzyme

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...